Loading Events

« All Events

  • This event has passed.

Live interview: Scott Scolnick presents the iLet bionic pancreas

August 6, 2015 @ 1:00 pm - 2:00 pm

1pm PT, 4pm ET, 9pm GMTiLet

What time is this where you are?

Join us HERE at the time and date of the event.

The Bionic Pancreas Team is a collaborative group from Boston University and Massachusetts General Hospital working together to make automated blood glucose control a reality.

Until a cure is found, the goal of the Bionic Pancreas Project is to reduce the impact of diabetes for people who have to live with it. To accomplish this, the team of engineers at Boston University is developing a Bionic Pancreas to automatically make decisions about insulin and glucagon dosing every five minutes.

On July 9, 2015, the Bionic Pancreas team announced the “iLet“.  The iLet houses two independent pumping systems, one for insulin and one for glucagon. These pumps are automatically commanded by insulin and glucagon dosing algorithms every 5 minutes.  Using Dexcom CGM technology, the iLet offers its own, built-in, continuous glucose monitor.  All that is required is a Dexcom sensor and transmitter and the iLet will replace a regular CGM receiver.

Scott has had type 1 diabetes for nearly 40 years. In his professional life, he has worn many different hats. He has his Masters in Counseling Psychology with a focus on marriage and family therapy. He worked in that area for 18 years. He has worked for two pump companies for over 12 years. During this time, he did talks around the country on dealing with the Emotional Impact of Diabetes. In 2013, Scott had the opportunity to be a subject in the Beacon Hill Study, in Boston, using the Bionic Pancreas. Most recently, he joined Boston University and is working in the College of Biomedical Engineering where is working with Ed Damiano and his team on the Bionic Pancreas. Scott with present the results of past and current clinical studies with this dual hormone system. He will also share the plans for the final pivitol studies and submission to the FDA.


August 6, 2015
1:00 pm - 2:00 pm


Emily Coles

Below Content Ad